---
schema_version: "secwatch.filing_event.v1"
accession: "0001285550-24-000061"
form_type: "8-K"
ticker: "CLPT"
cik: "0001285550"
company_name: "ClearPoint Neuro, Inc."
filed_at: "2024-05-16T23:59:59+00:00"
generated_at: "2026-06-01T19:25:15.462878+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# ClearPoint Neuro stockholders re-elect eight directors, approve incentive plan

## Summary
- All eight director nominees elected with over 11.6M votes for each; broker non-votes 6.8M.
- Ratification of Cherry Bekaert as auditor: 18.9M for, 68.6K against, 21K abstain.
- Advisory say-on-pay approved: 11.1M for, 629.5K against, 431.8K abstain; broker non-votes 6.8M.
- Stockholders approved Fifth Amended and Restated 2013 Incentive Compensation Plan: 11.0M for, 699.5K against.

## SEC filing metadata
- accession: 0001285550-24-000061
- form_type: 8-K
- ticker: CLPT
- cik: 0001285550
- company_name: ClearPoint Neuro, Inc.
- filed_at: 2024-05-16T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1285550/000128555024000061/0001285550-24-000061-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1285550/000128555024000061/clpt-20240516.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001285550-24-000061
- JSON: https://secwatch.observer/filing/0001285550-24-000061.json
- Plain text: https://secwatch.observer/filing/0001285550-24-000061.txt

## Source-grounded claims
- claim_id: 281b62957de01dfc723f1808bff9bf3a1959b5f2
  claim: ClearPoint Neuro, Inc. shareholders approved Ratification of Cherry Bekaert LLP as independent registered public accounting firm for 2024 at the 2024-12-31 meeting.
  evidence_excerpt: Ratification of Independent Registered Public Accounting Firm. The stockholders ratified the appointment of Cherry Bekaert LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024. The votes were cast as follows: For Against Abstentions Broker Non-Votes 18,941,669 68,614 21,001 —
  evidence_url: https://www.sec.gov/Archives/edgar/data/1285550/000128555024000061/0001285550-24-000061-index.htm
- claim_id: a157c7b0e55093be2f0ee7cc21f3236afc0a6ba4
  claim: ClearPoint Neuro, Inc. shareholders approved Approval of the Fifth Amended and Restated 2013 Incentive Compensation Plan.
  evidence_excerpt: Approval of the Fifth Amended and Restated 2013 Incentive Compensation Plan. The stockholders approved the Company’s Fifth Amended and Restated 2013 Incentive Compensation Plan. The votes were cast as follows: For Against Abstentions Broker Non-Votes 11,045,314 699,499 443,386 6,843,085
  evidence_url: https://www.sec.gov/Archives/edgar/data/1285550/000128555024000061/0001285550-24-000061-index.htm
- claim_id: a542e2871eda86756ea931934508bd39fa2ce42d
  claim: ClearPoint Neuro, Inc. shareholders approved Election of eight directors to serve until the 2025 annual meeting.
  evidence_excerpt: Election of Directors. The following named persons were elected as directors of the Company to serve until the 2025 annual meeting of stockholders or until their successors have been duly elected and qualified or until their earlier death, resignation, disqualification or removal. The votes were cast as follows: Name For Withheld Broker Non-Votes Joseph M. Burnett 12,037,171 151,028 6,843,085 R. John Fletcher 11,734,172 454,027 6,843,085 Lynnette C. Fallon 11,780,550 407,649 6,843,085 Pascal E.R. Girin 11,771,794 416,405 6,843,085 B. Kristine Johnson 11,730,889 457,310 6,843,085 Matthew B. Klein 11,850,463 337,736 6,843,085 Linda M. Liau 11,716,020 472,179 6,843,085 Timothy T. Richards 11,625,429 562,770 6,843,085
  evidence_url: https://www.sec.gov/Archives/edgar/data/1285550/000128555024000061/0001285550-24-000061-index.htm
- claim_id: b37efee36942da50e4d0c10d65593e8c4f8f3006
  claim: ClearPoint Neuro, Inc. shareholders approved Advisory approval of executive compensation.
  evidence_excerpt: Advisory approval of executive compensation. The stockholders, on an advisory basis, approved the compensation of the Company’s executives. The votes were cast as follows: For Against Abstentions Broker Non-Votes 11,126,888 629,515 431,796 6,843,085
  evidence_url: https://www.sec.gov/Archives/edgar/data/1285550/000128555024000061/0001285550-24-000061-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.